---
figid: PMC3693914__1478-811X-11-34-2
figlink: /pmc/articles/PMC3693914/figure/F2/
number: F2
caption: DA biosynthesis and degradation. The major pathway for DA biosynthesis starts
  at tyrosine or phenylalanine which can be hydroxylated by phenylalanine hydroxylase.
  Tyrosine is hydroxylated to form DOPA, now bearing the catechol moiety, by BH4-dependent
  tyrosine hydroxylase or alternatively by tyrosinase. Decarboxylation of DOPA by
  AADC leads then to DA. In another pathway for DA synthesis AADC action occurs before
  the hydroxylation at the aromatic ring. Tyramine is then oxidized by Cyp2D. Besides
  being a neurotransmitter itself, DA is also the precursor of epinephrine and norepinephrine.
  DA degradation is performed by COMT, MAO, ADH, ALDH and AR in variable order leading
  to DOPAC and HVA as the main endproducts. Phenolsulfotransferases and uridine diphosphoglucuronosyltransferases
  catalyze conjugation reactions with phosphate and glucuronic acid respectively.
  The relative contributions of the different enzymes are strongly species-, tissue-
  and celltype-dependent. The depicted reactions may occur in distinct compartments.
pmcid: PMC3693914
papertitle: Complexity of dopamine metabolism.
reftext: Johannes Meiser, et al. Cell Commun Signal. 2013;11:34-34.
pmc_ranked_result_index: '97649'
pathway_score: 0.9489328
filename: 1478-811X-11-34-2.jpg
figtitle: DA biosynthesis and degradation
year: '2013'
organisms: Homo sapiens
ndex: adf5f591-def6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3693914__1478-811X-11-34-2.html
  '@type': Dataset
  description: DA biosynthesis and degradation. The major pathway for DA biosynthesis
    starts at tyrosine or phenylalanine which can be hydroxylated by phenylalanine
    hydroxylase. Tyrosine is hydroxylated to form DOPA, now bearing the catechol moiety,
    by BH4-dependent tyrosine hydroxylase or alternatively by tyrosinase. Decarboxylation
    of DOPA by AADC leads then to DA. In another pathway for DA synthesis AADC action
    occurs before the hydroxylation at the aromatic ring. Tyramine is then oxidized
    by Cyp2D. Besides being a neurotransmitter itself, DA is also the precursor of
    epinephrine and norepinephrine. DA degradation is performed by COMT, MAO, ADH,
    ALDH and AR in variable order leading to DOPAC and HVA as the main endproducts.
    Phenolsulfotransferases and uridine diphosphoglucuronosyltransferases catalyze
    conjugation reactions with phosphate and glucuronic acid respectively. The relative
    contributions of the different enzymes are strongly species-, tissue- and celltype-dependent.
    The depicted reactions may occur in distinct compartments.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ADH7
  - ALDH5A1
  - ADHFE1
  - ADH6
  - ADH5
  - ALDH2
  - ALDH1A2
  - ADH4
  - ALDH1A1
  - ALDH7A1
  - ALDH3B1
  - ADH1B
  - ADH1A
  - ALDH3A2
  - ALDH1A3
  - TH
  - AR
  - ALDH9A1
  - COMT
  - ST8SIA4
  - ADH1C
  - DDC
  - ALDH3A1
  - CYP2D6
  - Methoxytyramine
  - 3,4-Dihydroxyphenylethanol
  - DOPET
  - 3,4-Dihydroxyphenylacetaldehyde
  - 3-Methoxy-4-hydroxyacetaldehyde
  - biopterin
  - Dopamine
  - Dopamine-3
  - Epinephrine
  - Homovanillic acid
  - L-DOPA
  - Norepinephrine
  - Phenylalanine
  - 3-0-sulfate
  - 4-0-sulfate
  - Tyramine
  - Tyrosine
  - 3,4-Dihydroxyphenylacetic acid
  - DOPAC
  - Homoprotocatechuic acid
  - 4-0-glucuronide
  - O-glucuronide
genes:
- word: ADH,AR
  symbol: ADH
  source: bioentities_symbol
  hgnc_symbol: ADH7
  entrez: '131'
- word: ALDH
  symbol: ALDH
  source: bioentities_symbol
  hgnc_symbol: ALDH5A1
  entrez: '7915'
- word: ADH,AR
  symbol: ADH
  source: bioentities_symbol
  hgnc_symbol: ADHFE1
  entrez: '137872'
- word: ADH,AR
  symbol: ADH
  source: bioentities_symbol
  hgnc_symbol: ADH6
  entrez: '130'
- word: ADH,AR
  symbol: ADH
  source: bioentities_symbol
  hgnc_symbol: ADH5
  entrez: '128'
- word: ALDH
  symbol: ALDH
  source: bioentities_symbol
  hgnc_symbol: ALDH2
  entrez: '217'
- word: ALDH
  symbol: ALDH
  source: bioentities_symbol
  hgnc_symbol: ALDH1A2
  entrez: '8854'
- word: ADH,AR
  symbol: ADH
  source: bioentities_symbol
  hgnc_symbol: ADH4
  entrez: '127'
- word: ALDH
  symbol: ALDH
  source: bioentities_symbol
  hgnc_symbol: ALDH1A1
  entrez: '216'
- word: ALDH
  symbol: ALDH
  source: bioentities_symbol
  hgnc_symbol: ALDH7A1
  entrez: '501'
- word: ALDH
  symbol: ALDH
  source: bioentities_symbol
  hgnc_symbol: ALDH3B1
  entrez: '221'
- word: ADH,AR
  symbol: ADH
  source: bioentities_symbol
  hgnc_symbol: ADH1B
  entrez: '125'
- word: ADH,AR
  symbol: ADH
  source: bioentities_symbol
  hgnc_symbol: ADH1A
  entrez: '124'
- word: ALDH
  symbol: ALDH
  source: bioentities_symbol
  hgnc_symbol: ALDH3A2
  entrez: '224'
- word: ALDH
  symbol: ALDH
  source: bioentities_symbol
  hgnc_symbol: ALDH1A3
  entrez: '220'
- word: TH
  symbol: TH
  source: hgnc_symbol
  hgnc_symbol: TH
  entrez: '7054'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: ALDH
  symbol: ALDH
  source: bioentities_symbol
  hgnc_symbol: ALDH9A1
  entrez: '223'
- word: COMT
  symbol: COMT
  source: hgnc_symbol
  hgnc_symbol: COMT
  entrez: '1312'
- word: PST
  symbol: PST
  source: hgnc_alias_symbol
  hgnc_symbol: ST8SIA4
  entrez: '7903'
- word: ADH,AR
  symbol: ADH
  source: bioentities_symbol
  hgnc_symbol: ADH1C
  entrez: '126'
- word: AADC
  symbol: AADC
  source: hgnc_alias_symbol
  hgnc_symbol: DDC
  entrez: '1644'
- word: ALDH
  symbol: ALDH
  source: bioentities_symbol
  hgnc_symbol: ALDH3A1
  entrez: '218'
- word: Cyp2D
  symbol: CYP2D
  source: hgnc_alias_symbol
  hgnc_symbol: CYP2D6
  entrez: '1565'
chemicals:
- word: Methoxytyramine
  source: MESH
  identifier: C001746
- word: 3,4-Dihydroxyphenylethanol
  source: MESH
  identifier: C005975
- word: DOPET
  source: MESH
  identifier: C005975
- word: 3,4-Dihydroxyphenylacetaldehyde
  source: MESH
  identifier: C007430
- word: 3-Methoxy-4-hydroxyacetaldehyde
  source: MESH
  identifier: C010972
- word: biopterin
  source: MESH
  identifier: D001708
- word: Dopamine
  source: MESH
  identifier: D004298
- word: Dopamine-3
  source: MESH
  identifier: D004298
- word: Epinephrine
  source: MESH
  identifier: D004837
- word: Homovanillic acid
  source: MESH
  identifier: D006719
- word: L-DOPA
  source: MESH
  identifier: D007980
- word: Norepinephrine
  source: MESH
  identifier: D009638
- word: Phenylalanine
  source: MESH
  identifier: D010649
- word: 3-0-sulfate
  source: MESH
  identifier: D013431
- word: 4-0-sulfate
  source: MESH
  identifier: D013431
- word: Tyramine
  source: MESH
  identifier: D014439
- word: Tyrosine
  source: MESH
  identifier: D014443
- word: 3,4-Dihydroxyphenylacetic acid
  source: MESH
  identifier: D015102
- word: DOPAC
  source: MESH
  identifier: D015102
- word: Homoprotocatechuic acid
  source: MESH
  identifier: D015102
- word: 4-0-glucuronide
  source: MESH
  identifier: D020719
- word: O-glucuronide
  source: MESH
  identifier: D020719
diseases: []
figid_alias: PMC3693914__F2
redirect_from: /figures/PMC3693914__F2
figtype: Figure
---
